BMS looks to RNA splicing to boost immunotherapiesBristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and Share XBMS looks to RNA splicing to boost immunotherapieshttps://pharmaphorum.com/news/bms-looks-to-rna-splicing-to-boost-immunotherapies/
